ITGAM and graft versus host disease: In summary, these results clearly show that CD11b+CD11c+ MDSCs do not impair the expansion and homing of allogeneic T cells in lymphatic and GVHD target organs but prevent GVHD induction by shifting the T-cell response towards type 2 immunity.